3-(2-Hydroxy-ethylamino)-1-phenyl-propan-1-one hydrochloride, 95.0%, 250mg

Trimethyl(2,3,4,5-tetramethylcyclopenta-2,4-dien-1-yl)silane, 98%, 1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,32 mm, Filmd. 0,35 µm, 1 Stück

4-Fluoro-4-phenylpiperidine hydrochloride, 95+%, 250mg

Co-Flocken, elektrolytisch 99,9 % 100 g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 500mg

(R)-2-Amino-5-methylhexanoic acid, 95.0%, 1g

4-bromo-5-chloro-2-methylpyridine, 97.00, 250mg

2-(2-ethyl-1H-imidazol-1-yl)ethanol, 95.0%, 1g

3,3'-Methylenediindole>98.0%(N)5g

2-Fluoro-4-methylpyridine-5-carboxyaldehyde, 95+%, 250mg

Ethyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 1g

4-Bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98%, 1g